The relationship between SNP of cholecystokinin gene and certain mental status and its forensic significance

Journal of Forensic Medicine

Volumn 24, Issue 4, 2008, Pages 284-287

  Yang, Jun ^a   Wang, Bao Jie ^a   Ding, Mei ^a   Pang, Hao ^a   Sun, Xue Fei ^a   Li, Zhong Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cholecystokinin; Forensic psychiatry; Mental status; Polymorphism, single nucleotide; Review publication type

Indexed keywords

CHOLECYSTOKININ;

DEPRESSION; FORENSIC PSYCHIATRY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CORRELATION; HUMAN; MENTAL DISEASE; MENTAL HEALTH; NONHUMAN; PARKINSON DISEASE; PATERNITY TEST; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR;

CHOLECYSTOKININ; FORENSIC MEDICINE; HUMANS; MENTAL DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES;

EID: 53349141559     PISSN: 10045619     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Tachikawa H, Harada S, Kawanishi Y, et al. Novel polymorphism in the promoter and coding regions of the human cholecystokinin B receptor gene: an association analysis with schizophrenia[J]. Am J Med Genet,1999,88(6):700-704.
2. Wank SA. Cholecystokinin receptors[J]. Am J Physiol, 1995,269(5 pt 1):G628-646.
3. Miyasaka K, Funakoshi A. Cholecystokinin and cholecystokinin receptors[J]. J Gastroenterol,2003,38 (1):1-13.
4. Noble F, Rogues BP. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology[J]. Prog Neurobiol,1999,58(4):349-379.
5. Chinese source.
6. Chinese source.
7. Fujii C, Harada S, Ohkashi N, et al. Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease [J]. Clin Genet, 1999,56(5):394-399.
8. Chinese source.
9. Chinese source.
10. Mercer LD, Beart PM, Home MK, et al. On the distribution of cholecystokinin B receptors in monkey brain[J]. Brain Res, 1996,738(2):313-318.
11. Crawley JN. Cholecystokinin-dopamine interactions[J]. Trends Pharmacol Sci,1991,12(6):232-236.
12. Harro J, Vasar E, Bradwejn J. CCK in aminal and human research on anxiety[J]. Trends Pharmacol Sci, 1993,14(6):244-249.
13. Redmond EM, Sitzmann JV, Cahill PA. Potential mechanisms for cardiovascular protective effect of ethanol[J]. Acta Pharmacol Sin, 2000,21(5):
14. Chinese source.
15. de Krom M, van der Schouw YT, Hendriks J, et al. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns[J]. Diabetes, 2007,56(1):276-280.
16. de Krom M, Hendriks J, Hillebrand J, et al. A polymorphism in the 3′untranslated region of the CCK gene is associated with anorexia nervosa in Dutch patients[J]. Psychiatr Genet,2006,16(6):239.
17. Wang Z, Wassink T, Andreasen NC, et al. Possible association of a cholecystokinin promoter variant to schizophrenia[J]. Am J Med Genet,2002,114(5):479-482.
18. Bowen T, Norton N, Jacobsen NJ, et al. Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder [J]. Mol Psychiatry, 1998,3(1):67-71.
19. Hattori E, Ehihara M, Yamada K, et al. Identification of a compound short tandem repeat stretch in the 5′ -upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia [J]. Mol Psychiatry, 2001,6(4):465-470.
20. Chinese source.
21. Shindo S, Yoshioka N. Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan[J]. Forensic Sci Int,2005,150(1):85-90.
22. Wang J, Si YM, Liu ZL, et al. Cholecystokinin, cholecystokinin -A receptor and cholecystokinin -B receptor gene polymorphisms in Parkinson's disease [J]. Pharmacogenetics,2003,13(6):365-369.
23. Hansen TV, Rehfeld JF, Nielsen FC. Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter [J]. Mol Psychiatry, 2000,5(4): 443-447.